IL-15 induces unspecific effector functions in human peptide-specific CD8+ T-cell cultures

Scandinavian Journal of Immunology

Volumn 56, Issue 6, 2002, Pages 602-610

  Lyngstrand, S T ^a   Wurtzen P A ^b   Odum N ^a   Nissen, M H ^a   Ropke C ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ALK ABELLÓ   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 2; PEPTIDE;

ANTIGEN SPECIFICITY; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EFFECTOR CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD; ANTIGENS, CD56; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTIGENS, VIRAL; APOPTOSIS; CELL DIVISION; CELL LINE; CELLS, CULTURED; CYTOKINES; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; INTERLEUKIN-15; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; PEPTIDE FRAGMENTS; RECEPTORS, INTERLEUKIN-15; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES, CYTOTOXIC; VIRAL MATRIX PROTEINS;

EID: 18744373848     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2002.01180.x     Document Type: Article

References (47)

1. Ahmed R, Gray D. Immunological memory and protective immunity: Understanding their relation. Science 1996;272:54-60.
2. + T cells during an acute virus infection. Immunity 1998;8:167-75.
3. + T cells with a predominant V beta usage during the primary immune response to HIV. Nature 1994;370:463-7.
4. Steven NM, Annels NE, Kumar A, Leese AM, Kurilla MG, Rickinson AB. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. J Exp Med 1997;185:1605-17.
5. Murali-Krishna K, Altman JD, Suresh M et al. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection. Immunity 1998;8:177-87.
6. Doherty PC. Cytotoxic T cell effector and memory function in viral immunity. Curr Top Microbiol Immunol 1996;206:1-14.
7. + T cells during viral infection. J Immunol 2001;166:795-9.
8. Bevan MJ, Goldrath AW. T-cell memory: You must remember this. Curr Biol 2000;10:R338-40.
9. Whitmire JK, Ahmed R. Costimulation in antiviral immunity: Differential requirements for CD4(+) and CD8(+) T cell responses. Curr Opin Immunol 2000;12:448-55.
10. Bachmann MF, Barner M, Viola A, Kopf M. Distinct kinetics of cytokine production and cytolysis in effector and memory T cells after viral infection. Eur J Immunol 1999;29:291-9.
11. + T cells. Curr Opin Immunol 1998;10:444-9.
12. Appay V, Rowland-Jones SL. RANTES: A versatile and controversial chemokine. Trends Immunol 2001;22:83-7.
13. Bamford RN, Grant AJ, Burton JD et al. The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 1994;91:4940-4.
14. Carson WE, Giri JG, Lindemann MJ et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 1994;180:1395-403.
15. Giri JG, Ahdieh M, Eisenman J et al. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 1994;13:2822-30.
16. DiSanto JP. Cytokines: Shared receptors, distinct functions. Curr Biol 1997;7:R424-26.
17. Waldmann T, Tagaya Y, Bamford R. Interleukin-2, interleukin-15, and their receptors. Int Rev Immunol 1998;16:205-26.
18. Waldmann TA, Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol 1999;17:19-49.
19. + T cells in vivo by IL-15. Immunity 1998;8:591-9.
20. Kennedy MK, Glaccum M, Brown SN et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 2000;191:771-80.
21. Liu CC, Perussia B, Young JD. The emerging role of IL-15 in NK-cell development. Immunol Today 2000;21:113-6.
22. + memory T cells by opposing cytokines. Science 2000;288:675-8.
23. Lodolce JP, Boone DL, Chai S et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 1998;9:669-76.
24. + T cells promotes minimal cell cycling but maximal cytokine synthesis and autonomous proliferation subsequently: A mechanism of self-regulation. J Immunol 1999;163:2443-51.
25. Wurtzen PA, Nissen MH, Claesson MH. Maturation of dendritic cells by recombinant human CD40L-trimer leads to a homogeneous cell population with enhanced surface marker expression and increased cytokine production. Scand J Immunol 2001;53:579-87.
26. Thulesen S, Jorgensen A, Gerwien J et al. Superantigens are presented by and activate thymocytes from infants. Exp Clin Immunogenet 1999;16:226-33.
27. Almonte M, Pucillo C, Damante G, Maio M. Cross-linking of HLA class II antigens modulates the release of tumor necrosis factor-alpha from the EBV-lymphoblastoid cell line JY. J Immunol 1993;151:5115-22.
28. Geisler C, Plesner T, Pallesen G, Skjodt K, Odum N, Larsen JK. Characterization and expression of the human T cell receptor-T3 complex by monoclonal antibody F101.01. Scand J Immunol 1988;27:685-96.
29. + T cells from human thymocytes by IL-15. J Interferon Cytokine Res 2001;21:905-11.
30. + T cells closely correlates with CD56 surface expression. J Immunol 2000;164:1148-52.
31. + natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J Immunol 1999;163:2314-21.
32. Tsuda K, Toda M, Kim G et al. Survival-promoting activity of IL-7 on IL-2-dependent cytotoxic T lymphocyte clones: Resultant induction of G1 arrest. J Immunol Methods 2000;236:37-51.
33. Carini C, Essex M. Interleukin 2-independent interleukin 7 activity enhances cytotoxic immune response of HIV-1-infected individuals. AIDS Res Hum Retroviruses 1994;10:121-30.
34. Plebanski M, Allsopp CE, Aidoo M, Reyburn H, Hill AV. Induction of peptide-specific primary cytotoxic T lymphocyte responses from human peripheral blood. Eur J Immunol 1995;25:1783-7.
35. Miller CL, Hooton JW, Gillis S, Paetkau V. IL-4 potentiates the IL-2-dependent proliferation of mouse cytotoxic T cells. J Immunol 1990;144:1331-7.
36. Widmer MB, Grabstein KH. Regulation of cytolytic T-lymphocyte generation by B-cell stimulatory factor. Nature 1987;326:795-8.
37. Malek TR, Porter BO, He YW. Multiple gamma c-dependent cytokines regulate T-cell development. Immunol Today 1999;20:71-6.
38. Giri JG, Kumaki S, Ahdieh M et al. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J 1995;14:3654-63.
39. Zheng L, Trageser CL, Willerford DM, Lenardo MJ. T cell growth cytokines cause the superinduction of molecules mediating antigen-induced T lymphocyte death. J Immunol 1998;160:763-9.
40. Gillis S, Smith KA. In vitro generation of tumor-specific cytotoxic lymphocytes. Secondary allogeneic mixed tumor lymphocyte culture of normal murine spleen cells. J Exp Med 1977;146:468-82.
41. Jonuleit H, Wiedemann K, Muller G et al. Induction of IL-15 messenger RNA and protein in human blood-derived dendritic cells: A role for IL-15 in attraction of T cells. J Immunol 1997;158:2610-5.
42. Blauvelt A, Asada H, Klaus-Kovtun V, Altman DJ, Lucey DR, Katz SI. Interleukin-15 mRNA is expressed by human keratinocytes Langerhans cells, and blood-derived dendritic cells and is downregulated by ultraviolet B radiation. J Invest Dermatol 1996;106:1047-52.
43. Tagaya Y, Kurys G, Thies TA et al. Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides. Proc Natl Acad Sci USA 1997;94:14444-9.
44. Kurys G, Tagaya Y, Bamford R, Hanover JA, Waldmann TA. The long signal peptide isoform and its alternative processing direct the intracellular trafficking of IL-15. J Biol Chem 2000;275:30653-9.
45. Croft M. Activation of naïve, memory and effector T cells. Curr Opin Immunol 1994;6:431-7.
46. Ponte M, Bertone S, Vitale C et al. Cytokine-induced expression of killer inhibitory receptors in human T lymphocytes. Eur Cytokine Netw 1998;9:69-72.
47. + T cells. Proc Natl Acad Sci USA 1998;95:1172-7.